Evidence map›Paper›PMID 41824283›Full record

ReviewCurrent heart failure reports2026

Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets.

Ellaline Cami, Eline Verghote, Emily Pecetto, Arantxa González, Ebba Brakenhielm, Elizabeth Av Jones, Vanessa Van Empel

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current heart failure reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ellaline Cami *Center for Molecular and Vascular Biology, KU Leuven, Herestraat 49, bus 911, Leuven, 3000, Belgium.
Eline Verghote *Department of Cardiology, Cardiovascular Research Institute (CARIM), Maastricht University Medical Centre, Universiteitssingel 50, Maastricht, 6229 ER, Netherlands.
Emily PecettoUniversity Rouen Normandie, INSERM EnVI, UMR1096, Rouen, F-76000, France.
Arantxa GonzálezProgram of Cardiovascular Diseases, Centro de Investigación Médica Aplicada (CIMA), Department of Cardiology and Cardiac Surgery, Department of Pathology, Anatomy and Physiology, Universidad de Navarra, Clínica Universidad de Navarra, Universidad de Navarra, IdiSNA, Avd. Pío XII 55, Pamplona, 31008, Spain.
Ebba BrakenhielmUniversity Rouen Normandie, INSERM EnVI, UMR1096, Rouen, F-76000, France.
Elizabeth Av JonesCenter for Molecular and Vascular Biology, KU Leuven, Herestraat 49, bus 911, Leuven, 3000, Belgium.
Vanessa Van EmpelDepartment of Cardiology, Cardiovascular Research Institute (CARIM), Maastricht University Medical Centre, Universiteitssingel 50, Maastricht, 6229 ER, Netherlands. vanessa.van.empel@mumc.nl.

Funding

Era4healthcvd 049/17935Fonds Wetenschappelijk Onderzoek, Belgium G0GE323NFrench Agence Nationale de la Recherche (ANR) ANR-23-R4HC-0010-01Spanish MCIU/AEI PCI2024-153490
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ComorbiditiesHeart failureHFpEFImmune profilingInflammation(max 6): Cytokines

Identifiers

PMID41824283
PMCPMC13391754

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.